Cipla Ltd.

Cipla’s Indore Oral Solid Dosage (OSD) plant has been designated by the World Economic Forum (WEF) as an ‘Advanced Fourth Industrial Revolution (4IR) Lighthouse’. The organization is amongst the first pharmaceutical companies in India & Asia and one of the few generic pharmaceutical companies in the world to be part of the Global Lighthouse Network.

Over the course of two years, Cipla has developed ‘Digital Automation Analytics’ (DAA) across a network of 22 India sites in parallel to unlock end to end costs, productivity and quality leadership. Cipla’s Indore OSD facility led this journey with 30+4IR use cases, Industrial Internet of Things, Digital, Advanced Analytics, Natural Language Processing (NLP), Robotic Process Automation, etc. This revolutionary technology has result in reduced manufacturing cost, greater agility, and speed. The impact generated across multiple fronts at Cipla’s Indore Oral Solid Dosage (OSD) facility includes 23% rise in productivity, 28% decrease in specific Greenhouse gas (GHG) emissions and quality enhancement.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.